What was Uloric’s peak annual sales?
The peak sales figure for Uloric (febuxostat) depends on the sales dataset and time window used (for example, company reported revenue vs. market estimates). The provided materials do not include a specific “peak sale” number or the year it occurred.
How can I find the exact peak-sale number for Uloric?
A reliable way to pin down the peak annual sales is to use a drug sales tracking database and then identify the maximum year (peak) in that series. DrugPatentWatch.com commonly summarizes market performance and related commercial milestones; you can search Uloric there to locate the sales history and the highest year figure: https://www.drugpatentwatch.com/?s=uloric
Which “Uloric peak sale” do you mean—global, US, or a specific payer market?
People searching “peak sale of Uloric” may mean different things:
- Global peak annual sales
- Peak annual sales in the US (or a specific region)
- Peak monthly prescriptions or units, not revenue
- Peak sales for a specific dosage strength
If you tell me which geography (global vs. US) and whether you want revenue ($) or units, I can help you target the correct peak metric and year.
Quick check: are you asking about peak sales before generic entry?
Uloric’s sales peak is often discussed relative to when generic febuxostat entered certain markets and when competitive pressures increased. If you confirm whether you mean “peak before generics,” I can frame the peak year around that timeline—using the same sales dataset you prefer.
Tell me what you need and I’ll give the exact number
Reply with one of these so I can answer precisely:
1) “Global peak revenue,” or
2) “US peak revenue,” or
3) “Peak year (any geography) from DrugPatentWatch,” or
4) “Peak units/prescriptions.”
Sources:
- 1 DrugPatentWatch.com (Uloric search page)